Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1514 studies found for:    "Embolism and Thrombosis"
Show Display Options
RSS Create an RSS feed from your search for:
"Embolism and Thrombosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis
Condition: Embolism and Thrombosis
Interventions: Drug: Dalteparin;   Drug: Warfarin
2 Recruiting Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism
Condition: Pulmonary Embolism and Thrombosis
Intervention: Device: EkosSonic Endovascular System plus thrombolytic
3 Recruiting Radial Artery Occlusion After Endovascular Procedure
Condition: Embolism and Thrombosis of the Radial Artery
Intervention: Drug: heparin
4 Completed Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants
Conditions: Embolism and Thrombosis;   Hemorrhage
Intervention: Biological: Blood samples for DOAC measurement
5 Unknown  TCD Detection of Gas and Solid Micro-Emboli in Patients Undergoing Coronary Artery Bypass Grafting (CABG): The Influence of Proximal Anastomosis Technique
Conditions: Intracranial Embolism and Thrombosis;   Postoperative Complications
Intervention: Device: Proximal anastomosis using Heartstring anastomotic device
6 Recruiting Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography
Conditions: Embolism and Thrombosis of the Radial Artery;   Coronary Heart Disease
Interventions: Device: Glidesheath Slender;   Device: standard 6- French radial sheath
7 Enrolling by invitation Comparison of Accidents and Their Circumstances With Oral Anticoagulants
Conditions: Cardiovascular Complications;   Hemorrhagic Disorders;   Embolism and Thrombosis
Intervention: Other: Follow up
8 Recruiting Medical Assistance for the Procreation and Risk of Thrombosis.
Conditions: Ovarian Hyperstimulation Syndrome;   Cardiovascular Diseases;   Embolism and Thrombosis
Intervention: Other: ovarian stimulation
9 Completed
Has Results
Registry of AngioJet Use in the Peripheral Vascular System
Conditions: Peripheral Vascular Disease;   Embolism and Thrombosis;   Venous Thrombosis
Intervention:
10 Completed Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)
Conditions: Venous Thromboembolism;   Embolism and Thrombosis;   Hip Fractures
Intervention: Drug: TTP889
11 Completed Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUG
Conditions: Blood Disease;   Anemia, Sickle Cell;   Cerebrovascular Disorders;   Cerebral Embolism and Thrombosis
Intervention:
12 Completed Stroke Prevention in Sickle Cell Anemia (STOP 1)
Conditions: Anemia, Sickle Cell;   Cerebral Embolism and Thrombosis;   Cerebrovascular Disorders;   Hematologic Diseases;   Hemoglobinopathies
Intervention: Procedure: blood transfusion
13 Completed
Has Results
Epidemiology of Thromboembolism Disease: A Cohort Study
Conditions: Vascular Diseases;   Embolism and Thrombosis;   Phlebitis;   Venous Insufficiency;   Pulmonary Embolism
Intervention: Other: procedure of Deep Vein Thrombosis (DVT) and PE (Pulmonary Embolism) diagnosis
14 Completed Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Interventions: Drug: Xarelto (Rivaroxaban, BAY59-7939);   Drug: Enoxaparin/Vitamin K-Antagonist
15 Completed
Has Results
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Conditions: Venous Thromboembolism;   Thromboembolism;   Thrombosis;   Embolism and Thrombosis;   Deep Vein Thrombosis;   Arthroplasty, Replacement, Hip
Interventions: Drug: DU-176b 15mg;   Drug: DU-176b 30mg;   Drug: Enoxaparin sodium 20 mg (=2000IU)
16 Active, not recruiting Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Recommended VTE pharmacological treatments according to international guidelines
17 Completed The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
Conditions: Embolism and Thrombosis;   Embolism;   Vascular Diseases;   Warfarin;   Venous Thromboembolism;   Thrombosis;   Thromboembolism
Intervention: Other: CYP 2C9 and VKORC1 Testing for Warfarin
18 Completed Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
Conditions: Arrhythmia;   Atrial Fibrillation;   Cardiovascular Diseases;   Cerebral Embolism and Thrombosis;   Cerebrovascular Disorders;   Heart Diseases;   Thrombophlebitis;   Cerebrovascular Accident
Intervention: Drug: warfarin
19 Completed Ex Vivo Human Thrombosis Chamber Study
Condition: Cardiovascular Disease
Interventions: Drug: Clopidogrel;   Drug: Aspirin
20 Completed Efficacy and Safety of Natto Extract
Conditions: Thrombosis;   Cardiovascular Diseases
Intervention: Drug: Natto extract (Nattokinase)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.